JENNIFER SANFILIPPO: Open Payments
NPI 1013391291 · WELLINGTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 26 payments from 8 companies in 2025. Trend: 2023 $397 · 2024 $244 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $390 |
| Novartis Pharmaceuticals Corporation | 6 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61 |
| Kestra Medical Technology Services, Inc. | 1 | $58 |
| ABIOMED | 2 | $48 |
| Abbott Laboratories | 1 | $40 |
| CVRx, Inc. | 2 | $31 |
| Medtronic, Inc. | 1 | $16 |
Products named: REPATHA, LEQVIO, JARDIANCE, Assure WCD, AVEIR, Barostim Neo System, LINQ II.
Industry payments across FL — which companies pay providers there.
